SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.
about
SMYD proteins: key regulators in skeletal and cardiac muscle development and functionThe long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA moleculesExploiting Epigenetic Alterations in Prostate Cancer.SMYD3 Promotes Homologous Recombination via Regulation of H3K4-mediated Gene Expression.MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 InhibitorCooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells.Role of several histone lysine methyltransferases in tumor development.SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer.SET and MYND domain containing protein 3 in cancer.Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.Structure and function of SET and MYND domain-containing proteins.Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma.Epb41l3 suppresses esophageal squamous cell carcinoma invasion and inhibits MMP2 and MMP9 expression.SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma.CHD1 Controls Cell Lineage Specification Through Zygotic Genome Activation.Increased progesterone receptor A expression in labouring human myometrium is associated with decreased promoter occupancy by the histone demethylase JARID1A.[Advances of histone methyltransferase SMYD3 in tumors].
P2860
Q26865167-DE0E2274-4DB3-41F2-A89E-C51462B4C47AQ33633347-74FCE5B1-8A76-4C0D-84DB-7806567E7D5EQ33755160-476678F4-C078-4466-ACB3-7F9D4C8A1F07Q33812604-8F5282E2-552E-47BF-BEF2-64FA91628661Q34497810-7F14DB36-67DD-45B9-92AC-38B6D8D34985Q35960316-5B5A93E6-F5CF-444B-90F6-C3DC4B76C625Q36160685-C45A54C0-6198-4ABD-9A70-4FCF36B1E78DQ36639797-8D316E4B-A4F0-46E5-932B-9228654DE9CDQ37551171-E82D2F77-8C2D-4559-B375-2FFFAC82EE8FQ37596853-7B983F8C-642C-4196-BB55-1886CA695498Q37745139-843BC7D1-14BF-4FA5-B323-F9C86F0FA25EQ38266428-D68BFEC1-C26D-4C6A-B02C-3182E766D665Q38314974-E7DB70FA-8115-4157-9FA2-4DC577B34681Q38430339-84C55CE4-DFA3-4C6D-959B-5751E1E34C03Q38791022-D5CEA818-4FBF-474C-9727-C168C451351AQ38874203-75C319E1-601C-4A5A-B957-F6C4FB46CA76Q39055609-4F229113-D968-4801-ABF4-F28AA2AEEBAEQ42036127-72FD4712-6E8E-4FD0-BA7E-5129D9EAE7C8Q42371520-1671E255-E49A-48E3-BFF6-545220773E2CQ49607461-223F1F31-5A04-434D-A6CB-01E38B653830Q51167403-2C3AF0C2-A6ED-47F1-86B6-CBA6AE7E101FQ55504750-4D2B4FDE-1CA9-4BDE-92F3-04F205018F67
P2860
SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
SMYD3 as an oncogenic driver i ...... drogen receptor transcription.
@en
SMYD3 as an oncogenic driver i ...... drogen receptor transcription.
@nl
type
label
SMYD3 as an oncogenic driver i ...... drogen receptor transcription.
@en
SMYD3 as an oncogenic driver i ...... drogen receptor transcription.
@nl
prefLabel
SMYD3 as an oncogenic driver i ...... drogen receptor transcription.
@en
SMYD3 as an oncogenic driver i ...... drogen receptor transcription.
@nl
P2093
P2860
P356
P1476
SMYD3 as an oncogenic driver i ...... drogen receptor transcription.
@en
P2093
Chang Wang
Hainan Liu
Hongbo Ren
Keqiang Yan
P2860
P304
P356
10.1093/JNCI/DJT304
P407
P577
2013-10-30T00:00:00Z